De novo homozygous mutation of the C1 inhibitor gene in a patient with hereditary angioedema
- 30 September 2013
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 132 (3), 748-750.e3
- https://doi.org/10.1016/j.jaci.2013.04.006
Abstract
No abstract availableKeywords
Funding Information
- CSL Behring
- CSL Behring and Shire HGT
- Shire HGT
- Shire HGT, CSL Behring, and SOBI
This publication has 13 references indexed in Scilit:
- Hereditary angio-oedemaThe Lancet, 2012
- A new case of homozygous C1-inhibitor deficiency suggests a role for Arg378 in the control of kinin pathway activationJournal of Allergy and Clinical Immunology, 2010
- New insights into hereditary angio‐oedema: Molecular diagnosis and therapyAustralasian Journal of Dermatology, 2010
- First case of homozygous C1 inhibitor deficiencyJournal of Allergy and Clinical Immunology, 2006
- Autoantibodies and Lymphoproliferative Diseases in Acquired C1-Inhibitor DeficienciesMedicine, 2003
- Frequent de novo mutations and exon deletions in the C1inhibitor gene of patients with angioedemaJournal of Allergy and Clinical Immunology, 2000
- Molecular Genetics of C1 InhibitorImmunobiology, 1998
- Complete nucleotide sequence of the gene for human C1 inhibitor with an unusually high density of Alu elementsEuropean Journal of Biochemistry, 1991
- A simple salting out procedure for extracting DNA from human nucleated cellsNucleic Acids Research, 1988
- Human inhibitor of the first component of complement, C1: characterization of cDNA clones and localization of the gene to chromosome 11.Proceedings of the National Academy of Sciences, 1986